NFE2L2 and liver cancer: Nie et al. found that retinoblastoma (Rb), nuclear factor erythroid 2-related factor 2 (NRF2) and metallothionein-1G (MT-1G) inhibit sorafenib-induced ferroptosis of liver cancer cells and reduce sensitivity to sorafenib [39].